Could a common arthritis drug ease a rare liver disease?
NCT ID NCT03561584
First seen Mar 23, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study tested whether sulfasalazine, a drug used for arthritis and inflammatory bowel disease (IBD), can help people with primary sclerosing cholangitis (PSC), a rare liver condition. About 32 adults with both PSC and IBD took either sulfasalazine or a placebo for several months. Researchers measured changes in liver enzymes and symptoms to see if the drug is safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Chestnut Hill, Massachusetts, 02467, United States
Conditions
Explore the condition pages connected to this study.